🇺🇸 FDA
Pipeline program

Control (Standard treatment)

CT-DRM-001

Unknown small_molecule active

Quick answer

Control (Standard treatment) for Moisture Associated Skin Damage is a Unknown program (small_molecule) at Grace Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Grace Therapeutics
Indication
Moisture Associated Skin Damage
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials